Azithromycin Tablets Solicitation

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-26-R-0008

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued a presolicitation notice for the procurement of Azithromycin Tablets. This solicitation, identified by procurement number SPE2D2-26-R-0008, is intended to secure a reliable supply of pharmaceutical-grade Azithromycin tablets for federal use, supporting the agency’s ongoing commitment to ensuring the availability of essential medical supplies for military and related operations. The scope of this procurement encompasses the manufacturing and delivery of Azithromycin tablets, with the updated schedule of supplies and pricing sheet provided as part of the solicitation amendments. Contractors are encouraged to review these documents carefully to understand the specific requirements and quantities involved. The primary objective is to obtain high-quality pharmaceutical preparations that meet all applicable federal standards, ensuring efficacy, safety, and timely delivery. This opportunity is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and product service code 6505, indicating drugs and biologicals. The solicitation is managed by DLA Troop Support, a federal office within the Defense Logistics Agency, and is posted on SAM.gov with the opportunity ID d4bd5c7057594cc893371f5fc8c77769. The notice remains active, and interested parties should refer to the provided URL for access to all relevant attachments and updates. Key points of contact for this solicitation are Nancy Fernandez ([email protected], 445-737-0713) and Jason Wray ([email protected], 445-737-6304), who can provide further information regarding the procurement process and requirements. Contractors should note the presolicitation status, indicating that formal solicitation documents and instructions will follow, and are advised to monitor the notice for any additional amendments or clarifications. While the notice does not specify set-aside requirements or special considerations, it is essential for prospective bidders to ensure compliance with all federal regulations governing pharmaceutical manufacturing and supply. The deliverables are expected to remain consistent throughout the contract lifecycle, focusing on the provision of Azithromycin tablets as outlined in the updated schedule. Overall, this procurement represents a significant opportunity for qualified manufacturers in the pharmaceutical sector to partner with the Department of Defense in supporting critical healthcare needs. Contractors with the capability to meet the outlined requirements are encouraged to review the attached documents and prepare for the forthcoming solicitation phase.
Documents13